vs

Side-by-side financial comparison of BrightView Holdings, Inc. (BV) and Hologic (HOLX). Click either name above to swap in a different company.

Hologic is the larger business by last-quarter revenue ($1.0B vs $614.7M, roughly 1.7× BrightView Holdings, Inc.). Hologic runs the higher net margin — 17.1% vs -2.5%, a 19.6% gap on every dollar of revenue. On growth, BrightView Holdings, Inc. posted the faster year-over-year revenue change (2.6% vs 2.5%). Hologic produced more free cash flow last quarter ($215.2M vs $-18.6M). Over the past eight quarters, Hologic's revenue compounded faster (1.5% CAGR vs -4.4%).

BrightView Holdings, Inc. is a leading US commercial landscaping services provider. It offers solutions including landscape design, installation, maintenance, irrigation management, and snow and ice removal, serving corporate campuses, retail centers, residential communities, and public sector properties.

Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.

BV vs HOLX — Head-to-Head

Bigger by revenue
HOLX
HOLX
1.7× larger
HOLX
$1.0B
$614.7M
BV
Growing faster (revenue YoY)
BV
BV
+0.0% gap
BV
2.6%
2.5%
HOLX
Higher net margin
HOLX
HOLX
19.6% more per $
HOLX
17.1%
-2.5%
BV
More free cash flow
HOLX
HOLX
$233.8M more FCF
HOLX
$215.2M
$-18.6M
BV
Faster 2-yr revenue CAGR
HOLX
HOLX
Annualised
HOLX
1.5%
-4.4%
BV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BV
BV
HOLX
HOLX
Revenue
$614.7M
$1.0B
Net Profit
$-15.2M
$179.1M
Gross Margin
18.6%
56.0%
Operating Margin
-1.2%
22.6%
Net Margin
-2.5%
17.1%
Revenue YoY
2.6%
2.5%
Net Profit YoY
-46.2%
-10.9%
EPS (diluted)
$-0.26
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BV
BV
HOLX
HOLX
Q4 25
$614.7M
$1.0B
Q3 25
$702.7M
$1.0B
Q2 25
$708.3M
$1.0B
Q1 25
$662.6M
$1.0B
Q4 24
$599.2M
$1.0B
Q3 24
$728.7M
$988.0M
Q2 24
$738.8M
$1.0B
Q1 24
$672.9M
$1.0B
Net Profit
BV
BV
HOLX
HOLX
Q4 25
$-15.2M
$179.1M
Q3 25
$27.7M
$187.2M
Q2 25
$32.3M
$194.9M
Q1 25
$6.4M
$-17.4M
Q4 24
$-10.4M
$201.0M
Q3 24
$25.6M
$178.6M
Q2 24
$23.5M
$194.5M
Q1 24
$33.7M
$169.9M
Gross Margin
BV
BV
HOLX
HOLX
Q4 25
18.6%
56.0%
Q3 25
25.1%
55.6%
Q2 25
24.1%
56.3%
Q1 25
22.3%
37.5%
Q4 24
21.2%
56.8%
Q3 24
25.0%
56.4%
Q2 24
24.0%
55.4%
Q1 24
22.6%
53.3%
Operating Margin
BV
BV
HOLX
HOLX
Q4 25
-1.2%
22.6%
Q3 25
7.9%
22.6%
Q2 25
8.1%
24.9%
Q1 25
3.4%
-0.7%
Q4 24
-0.1%
22.5%
Q3 24
7.1%
23.3%
Q2 24
6.6%
24.1%
Q1 24
9.2%
20.7%
Net Margin
BV
BV
HOLX
HOLX
Q4 25
-2.5%
17.1%
Q3 25
3.9%
17.8%
Q2 25
4.6%
19.0%
Q1 25
1.0%
-1.7%
Q4 24
-1.7%
19.7%
Q3 24
3.5%
18.1%
Q2 24
3.2%
19.2%
Q1 24
5.0%
16.7%
EPS (diluted)
BV
BV
HOLX
HOLX
Q4 25
$-0.26
$0.79
Q3 25
$0.21
$0.84
Q2 25
$0.15
$0.86
Q1 25
$-0.03
$-0.08
Q4 24
$-0.20
$0.87
Q3 24
$0.20
$0.75
Q2 24
$0.10
$0.82
Q1 24
$0.17
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BV
BV
HOLX
HOLX
Cash + ST InvestmentsLiquidity on hand
$37.0M
$2.4B
Total DebtLower is stronger
$801.1M
$2.5B
Stockholders' EquityBook value
$1.3B
$5.2B
Total Assets
$3.3B
$9.2B
Debt / EquityLower = less leverage
0.64×
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BV
BV
HOLX
HOLX
Q4 25
$37.0M
$2.4B
Q3 25
$74.5M
$2.2B
Q2 25
$79.1M
$1.9B
Q1 25
$141.3M
$1.6B
Q4 24
$98.3M
$2.0B
Q3 24
$140.4M
$2.3B
Q2 24
$115.9M
$2.4B
Q1 24
$177.3M
$2.2B
Total Debt
BV
BV
HOLX
HOLX
Q4 25
$801.1M
$2.5B
Q3 25
$790.2M
$2.5B
Q2 25
$790.7M
$2.5B
Q1 25
$798.9M
$2.5B
Q4 24
$796.5M
$2.5B
Q3 24
$802.5M
$2.5B
Q2 24
$2.5B
Q1 24
$2.6B
Stockholders' Equity
BV
BV
HOLX
HOLX
Q4 25
$1.3B
$5.2B
Q3 25
$1.3B
$5.0B
Q2 25
$1.3B
$4.8B
Q1 25
$1.3B
$4.6B
Q4 24
$1.3B
$4.8B
Q3 24
$1.3B
$5.1B
Q2 24
$1.3B
$5.0B
Q1 24
$1.2B
$4.8B
Total Assets
BV
BV
HOLX
HOLX
Q4 25
$3.3B
$9.2B
Q3 25
$3.4B
$9.0B
Q2 25
$3.4B
$8.8B
Q1 25
$3.3B
$8.5B
Q4 24
$3.3B
$8.7B
Q3 24
$3.4B
$9.2B
Q2 24
$3.4B
$8.9B
Q1 24
$3.4B
$8.7B
Debt / Equity
BV
BV
HOLX
HOLX
Q4 25
0.64×
0.48×
Q3 25
0.61×
0.50×
Q2 25
0.62×
0.52×
Q1 25
0.63×
0.55×
Q4 24
0.63×
0.53×
Q3 24
0.63×
0.49×
Q2 24
0.51×
Q1 24
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BV
BV
HOLX
HOLX
Operating Cash FlowLast quarter
$36.1M
$229.9M
Free Cash FlowOCF − Capex
$-18.6M
$215.2M
FCF MarginFCF / Revenue
-3.0%
20.5%
Capex IntensityCapex / Revenue
8.9%
1.4%
Cash ConversionOCF / Net Profit
1.28×
TTM Free Cash FlowTrailing 4 quarters
$17.2M
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BV
BV
HOLX
HOLX
Q4 25
$36.1M
$229.9M
Q3 25
$84.4M
$355.1M
Q2 25
$55.7M
$343.3M
Q1 25
$91.2M
$169.4M
Q4 24
$60.5M
$189.3M
Q3 24
$53.5M
$367.0M
Q2 24
$42.6M
$405.8M
Q1 24
$83.3M
$292.4M
Free Cash Flow
BV
BV
HOLX
HOLX
Q4 25
$-18.6M
$215.2M
Q3 25
$26.0M
$341.4M
Q2 25
$-47.8M
$330.5M
Q1 25
$57.6M
$153.9M
Q4 24
$1.8M
$172.5M
Q3 24
$21.1M
$350.6M
Q2 24
$19.3M
$385.3M
Q1 24
$70.7M
$279.6M
FCF Margin
BV
BV
HOLX
HOLX
Q4 25
-3.0%
20.5%
Q3 25
3.7%
32.5%
Q2 25
-6.7%
32.3%
Q1 25
8.7%
15.3%
Q4 24
0.3%
16.9%
Q3 24
2.9%
35.5%
Q2 24
2.6%
38.1%
Q1 24
10.5%
27.5%
Capex Intensity
BV
BV
HOLX
HOLX
Q4 25
8.9%
1.4%
Q3 25
8.3%
1.3%
Q2 25
14.6%
1.3%
Q1 25
5.1%
1.5%
Q4 24
9.8%
1.6%
Q3 24
4.4%
1.7%
Q2 24
3.2%
2.0%
Q1 24
1.9%
1.3%
Cash Conversion
BV
BV
HOLX
HOLX
Q4 25
1.28×
Q3 25
3.05×
1.90×
Q2 25
1.72×
1.76×
Q1 25
14.25×
Q4 24
0.94×
Q3 24
2.09×
2.05×
Q2 24
1.81×
2.09×
Q1 24
2.47×
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BV
BV

Landscape Maintenance$368.0M60%
Development Services Segment$179.2M29%
Snow Removal$68.4M11%

HOLX
HOLX

Molecular Diagnostics$255.3M24%
Breast Imaging$219.9M21%
Services$216.4M21%
Capital Equipment Componentsand Software$187.2M18%
Cytology Perinatal$76.0M7%
Interventional Breast Solutions$71.2M7%
Blood Screening$8.4M1%
Other Typeof Revenue$5.4M1%

Related Comparisons